We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Platelets and Monocytes Communicate in Newly Discovered Immune Pathway

Hands in pink vinyl gloves hold a test tube containing blood.
Credit: Karolina Kaboompics/ Pexels
Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: 1 minute

Monocytes are white blood cells, known as leukocytes. They are an important part of the innate immune system and contribute to host defense in the blood by secreting large quantities of pro-inflammatory cytokines.


Abnormal activity of monocytes leads to hyperinflammation, i.e. very severe inflammation, as well as life-threatening cytokine storms. On the other hand, disturbed monocyte function is associated with "immune paralysis". In this condition, the immune system's ability to fight off invaders such as viruses and bacteria is inhibited. This increases susceptibility to infections. "It is therefore crucial to understand how the functions of monocytes are regulated," says senior and corresponding author Prof. Dr. Bernardo Franklin from the Institute of Innate Immunity at the UKB and the Cluster of Excellence ImmunoSensation2 at the University of Bonn, explaining the motivation to investigate the role of platelets in the regulation of monocyte-induced inflammation.

Want more breaking news?

Subscribe to Technology Networks’ daily newsletter, delivering breaking science news straight to your inbox every day.

Subscribe for FREE

Platelets as a central checkpoint in immune defense

Platelets play a central role in blood clotting, but are also thought to perform important functions in the immune system. Prof. Franklin's research team has already identified platelets as an important regulator of inflammation. They now report that a low platelet count in the rare blood disorder immune thrombocytopenia (ITP) or the artificial removal of platelets from healthy monocytes results in "immunoparalysis". This is characterized by a disturbed cytokine reaction and is an immunological challenge. "Remarkably, supplementing monocytes with fresh platelets reverses this condition and restores the monocyte cytokine response," says corresponding and co-first author Dr. Ibrahim Hawwari, a postdoctoral fellow of the University of Bonn at the Institute of Innate Immunity at the UKB. The Bonn researchers discovered that the pro-inflammatory signals, including NF-κB and p38 MAPK, propagate from platelets to monocytes and maintain their inflammatory capacity. "Platelet vesicles as an extended arm of platelets control this intercellular communication," says co-first author Lukas Roßnagel, PhD student ot the University of Bonn at the Institute of Innate Immunity of the UKB.


The results of the study point to a new intercellular communication mechanism in which platelets regulate monocyte function. "Clinically, this suggests potential therapeutic strategies to counteract monocyte immune paralysis in conditions such as ITP and other inflammatory diseases with the addition of platelets," says Prof. Franklin, who hopes that an understanding of platelet-monocyte interactions will lead to improved treatment of immune disorders and related diseases.


Reference: Hawwari I, Rossnagel L, Rosero N, et al. Platelet transcription factors license the pro-inflammatory cytokine response of human monocytes. EMBO Molecular Medicine. 2024:1-29. doi: 10.1038/s44321-024-00093-3


This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source. Our press release publishing policy can be accessed here.